PDT Partners’s TherapeuticsMD TXMD Stock Holding History

PDT Partners’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-216	Closed	-$85K	–	1577
2015 Q2	$85K	Buy	+216	New	+$76.2K	﹤0.01%	1302

Other funds holding TXMD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PDT Partners's TXMD Position: Q3 2015 in Review

PDT Partners sold out of TherapeuticsMD (TXMD) in Q3 2015, closing a stake of 216 shares — an estimated $85K sold.

PDT Partners first reported a position in TXMD in Q2 2015 and held it in 1 quarter. The position peaked at $85K in Q2 2015. 114 funds tracked by Wall St. Rank hold TXMD as of Q3 2015.

PDT Partners reported no remaining TherapeuticsMD position as of Q3 2015 after selling out during the quarter.
PDT Partners sold 216 TherapeuticsMD shares in Q3 2015, an estimated $85K.
PDT Partners first reported a position in TherapeuticsMD in Q2 2015 and held it in 1 quarter.
PDT Partners's TherapeuticsMD position peaked at $85K in Q2 2015.
114 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2015.

Based on PDT Partners's 13F filing for Q3 2015, filed 16 Nov 2015.